Onsdag 30 Oktober | 09:25:38 Europe / Stockholm

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Kalender

Tid*
2025-12-04 - Årsstämma
2025-11-04 12:00 Bokslutskommuniké 2025
2025-08-19 07:30 Kvartalsrapport 2025-Q3
2025-04-06 07:30 Kvartalsrapport 2025-Q2
2025-02-04 07:30 Kvartalsrapport 2025-Q1
2024-12-05 - Årsstämma
2024-11-05 12:00 Bokslutskommuniké 2024
2024-08-20 - Kvartalsrapport 2024-Q3
2024-05-13 - X-dag halvårsutdelning COLO B 5
2024-05-07 - Kvartalsrapport 2024-Q2
2024-02-09 - Kvartalsrapport 2024-Q1
2023-12-08 - X-dag halvårsutdelning COLO B 16
2023-12-07 - Årsstämma
2023-11-09 - Bokslutskommuniké 2023
2023-08-17 - Kvartalsrapport 2023-Q3
2023-05-15 - X-dag halvårsutdelning COLO B 5
2023-05-11 - Kvartalsrapport 2023-Q2
2023-02-03 - Kvartalsrapport 2023-Q1
2022-12-02 - X-dag halvårsutdelning COLO B 15
2022-12-01 - Årsstämma
2022-11-07 - Bokslutskommuniké 2022
2022-08-17 - Kvartalsrapport 2022-Q3
2022-05-09 - X-dag halvårsutdelning COLO B 5
2022-05-05 - Kvartalsrapport 2022-Q2
2022-01-25 - Kvartalsrapport 2022-Q1
2021-12-03 - X-dag halvårsutdelning COLO B 14
2021-12-02 - Årsstämma
2021-11-01 - Bokslutskommuniké 2021
2021-08-18 - Kvartalsrapport 2021-Q3
2021-05-10 - X-dag halvårsutdelning COLO B 5
2021-05-06 - Kvartalsrapport 2021-Q2
2021-02-06 - Kvartalsrapport 2021-Q1
2020-12-04 - X-dag halvårsutdelning COLO B 13
2020-12-03 - Årsstämma
2020-11-03 - Bokslutskommuniké 2020
2020-08-18 - Kvartalsrapport 2020-Q3
2020-05-11 - X-dag halvårsutdelning COLO B 5
2020-05-06 - Kvartalsrapport 2020-Q2
2020-02-06 - Kvartalsrapport 2020-Q1
2019-12-06 - X-dag halvårsutdelning COLO B 12
2019-12-05 - Årsstämma
2019-11-05 - Bokslutskommuniké 2019
2019-08-14 - Kvartalsrapport 2019-Q3
2019-05-06 - X-dag halvårsutdelning COLO B 5
2019-05-02 - Kvartalsrapport 2019-Q2
2019-02-05 - Kvartalsrapport 2019-Q1
2018-12-06 - X-dag halvårsutdelning COLO B 11
2018-12-05 - Årsstämma
2018-11-01 - Bokslutskommuniké 2018
2018-08-08 - Kvartalsrapport 2018-Q3
2018-05-07 - X-dag halvårsutdelning COLO B 5
2018-05-03 - Kvartalsrapport 2018-Q2
2018-02-01 - Kvartalsrapport 2018-Q1
2017-12-08 - X-dag halvårsutdelning COLO B 10.5
2017-12-07 - Årsstämma
2017-11-02 - Bokslutskommuniké 2017
2017-08-16 - Kvartalsrapport 2017-Q3
2017-05-08 - X-dag halvårsutdelning COLO B 4.5
2017-05-03 - Kvartalsrapport 2017-Q2
2017-02-01 - Kvartalsrapport 2017-Q1
2016-12-06 - X-dag halvårsutdelning COLO B 9
2016-12-05 - Årsstämma
2016-11-02 - Bokslutskommuniké 2016
2016-08-16 - Kvartalsrapport 2016-Q3
2016-05-09 - X-dag halvårsutdelning COLO B 4.5
2016-05-03 - Kvartalsrapport 2016-Q2
2016-02-02 - Kvartalsrapport 2016-Q1
2015-12-10 - X-dag halvårsutdelning COLO B 8
2015-12-09 - Årsstämma
2015-11-03 - Bokslutskommuniké 2015
2015-08-11 - Kvartalsrapport 2015-Q3
2015-05-07 - X-dag halvårsutdelning COLO B 4.5
2015-05-05 - Kvartalsrapport 2015-Q2
2015-01-29 - Kvartalsrapport 2015-Q1
2014-12-05 - X-dag halvårsutdelning COLO B 7.5
2014-12-04 - Årsstämma
2014-10-30 - Bokslutskommuniké 2014
2014-05-08 - X-dag halvårsutdelning COLO B 4
2013-12-06 - X-dag halvårsutdelning COLO B 7
2013-12-05 - Årsstämma
2013-10-31 - Bokslutskommuniké 2013
2013-08-13 - Kvartalsrapport 2013-Q3
2013-05-06 - X-dag halvårsutdelning COLO B 3
2013-04-30 - Kvartalsrapport 2013-Q2
2013-01-30 - Kvartalsrapport 2013-Q1
2012-12-19 - Split COLO B 1:5
2012-12-11 - Årsstämma
2012-11-06 - Bokslutskommuniké 2012
2012-08-15 - Kvartalsrapport 2012-Q3
2012-04-26 - Kvartalsrapport 2012-Q2
2012-01-25 - Kvartalsrapport 2012-Q1
2011-12-08 - X-dag ordinarie utdelning COLO B 14.00 DKK
2011-12-07 - Årsstämma
2011-11-01 - Bokslutskommuniké 2011
2011-08-17 - Kvartalsrapport 2011-Q3
2011-06-21 - Kapitalmarknadsdag 2011
2011-05-04 - Kvartalsrapport 2011-Q2
2011-01-26 - Kvartalsrapport 2011-Q1
2010-12-02 - X-dag ordinarie utdelning COLO B 10.00 DKK
2009-12-02 - X-dag ordinarie utdelning COLO B 7.00 DKK
2004-12-16 - Split COLO B 1:2

Beskrivning

LandDanmark
ListaLarge Cap Copenhagen
SektorHälsovård
IndustriMedicinteknik
Coloplast är verksamt inom medicinteknik. Bolaget är en utvecklare av produkter och tjänster anpassade för människor med olika medicinska tillstånd. Bolagets produktportfölj består av vårdutrustning och används huvudsakligen inom områdena stomi, inkontinens, urologi, samt hud- och sårvård. Idag är bolaget verksamma på en global marknad via egna försäljningskanaler. Bolaget grundades 1954 och har sitt huvudkontor i Humlebæk, Danmark.
2022-01-25 13:08:38

Report on transactions of executives and related parties in Coloplast shares and related securities

According to the Market Abuse Regulation article 19 Coloplast is obliged to report on the transactions of executives and their related parties in Coloplast shares and related securities.

The below transactions concern allocation of share options.

For further details, reference is made to Coloplast’s Remuneration Policy which was adopted in 2021. The policy is available on the group website at this address:
https://investor.coloplast.com/investor-relations/governance/policies_and_positions/

1Details of the person discharging managerial responsibilities/person closely associated
a)NameKristian Villumsen
2Reason for the notification
a)Position/statusPresident & CEO
b)Initial notification/AmendmentInitial notification
3Details of the issuer, emission allowance market participant, auction platform, auctioneer, or auction monitor
a)NameColoplast A/S (CVR-no.: 69749917)
b)LEI529900NN7SOJ5QG82X67
4Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)Description of the financial instrument, type of instrumentShare options relating to B shares
Identification codeISIN: DK0060448595 (B shares)
b)Nature of the transactionShare option allocation
c)Price and volumePriceVolume
0.0047,454
d)Aggregated information 
-        Aggregated volume47,454 share options
-        PriceDKK 0.00
e)Date of the transaction2022-01-25, 12:00 UTC
f)Place of the transactionOutside a trading venue

 

1Details of the person discharging managerial responsibilities/person closely associated
a)NameAnders Lonning-Skovgaard
2Reason for the notification
a)Position/statusExecutive Vice President & CFO
b)Initial notification/AmendmentInitial notification
3Details of the issuer, emission allowance market participant, auction platform, auctioneer, or auction monitor
a)NameColoplast A/S (CVR-no.: 69749917)
b)LEI529900NN7SOJ5QG82X67
4Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)Description of the financial instrument, type of instrumentShare options relating to B shares
Identification codeISIN: DK0060448595 (B shares)
b)Nature of the transactionShare option allocation
c)Price and volumePriceVolume
0.0023,465
d)Aggregated information 
-        Aggregated volume23,465 share options
-        PriceDKK 0.00
e)Date of the transaction2022-01-25, 12:00 UTC
f)Place of the transactionOutside a trading venue

 

1Details of the person discharging managerial responsibilities/person closely associated
a)NamePaul Marcun
2Reason for the notification
a)Position/statusExecutive Vice President, Growth
b)Initial notification/AmendmentInitial notification
3Details of the issuer, emission allowance market participant, auction platform, auctioneer, or auction monitor
a)NameColoplast A/S (CVR-no.: 69749917)
b)LEI529900NN7SOJ5QG82X67
4Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)Description of the financial instrument, type of instrumentShare options relating to B shares
Identification codeISIN: DK0060448595 (B shares)
b)Nature of the transactionShare option allocation
c)Price and volumePriceVolume
0.0024,048
d)Aggregated information 
-        Aggregated volume24,048 share options
-        PriceDKK 0.00
e)Date of the transaction2022-01-25, 12:00 UTC
f)Place of the transactionOutside a trading venue

 

1Details of the person discharging managerial responsibilities/person closely associated
a)NameAllan Rasmussen
2Reason for the notification
a)Position/statusExecutive Vice President, Global Operations
b)Initial notification/AmendmentInitial notification
3Details of the issuer, emission allowance market participant, auction platform, auctioneer, or auction monitor
a)NameColoplast A/S (CVR-no.: 69749917)
b)LEI529900NN7SOJ5QG82X67
4Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)Description of the financial instrument, type of instrumentShare options relating to B shares
Identification codeISIN: DK0060448595 (B shares)
b)Nature of the transactionShare option allocation
c)Price and volumePriceVolume
0.0021,073
d)Aggregated information 
-        Aggregated volume21,073 share options
-        PriceDKK 0.00
e)Date of the transaction2022-01-25, 12:00 UTC
f)Place of the transactionOutside a trading venue

 

1Details of the person discharging managerial responsibilities/person closely associated
a)NameNicolai Buhl Andersen
2Reason for the notification
a)Position/statusExecutive Vice President, Innovation
b)Initial notification/AmendmentInitial notification
3Details of the issuer, emission allowance market participant, auction platform, auctioneer, or auction monitor
a)NameColoplast A/S (CVR-no.: 69749917)
b)LEI529900NN7SOJ5QG82X67
4Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)Description of the financial instrument, type of instrumentShare options relating to B shares
Identification codeISIN: DK0060448595 (B shares)
b)Nature of the transactionShare option allocation
c)Price and volumePriceVolume
0.0018,797
d)Aggregated information 
-        Aggregated volume18,797 share options
-        PriceDKK 0.00
e)Date of the transaction2022-01-25, 12:00 UTC
f)Place of the transactionOutside a trading venue



For further information, please contact

  
Investors and analysts
Anders Lonning-Skovgaard
Executive Vice President, CFO
Tel. +45 4911 1111

Ellen Bjurgert
Vice President, Investor Relations
Tel. +45 4911 1800 /+45 4911 3376
Email: dkebj@coloplast.com

Aleksandra Dimovska
Sr. Manager, Investor Relations
Tel. +45 4911 1800 / +45 4911 2458
Email: dkadim@coloplast.com                                                                       

Press and the media
Dennis Kaysen
Sr. Director, Communications
Tel. +45 4911 2608
Email: dkdk@coloplast.com

Address
Coloplast A/S
Holtedam 1
DK-3050 Humlebaek
Denmark
Company reg. (CVR) no. 69749917

Website
www.coloplast.com

 

This announcement is available in a Danish and an English-language version. In the event of discrepancies, the Danish version shall prevail.

Coloplast develops products and services that make life easier for people with very personal and private medical conditions. Working closely with the people who use our products, we create solutions that are sensitive to their special needs. We call this intimate health care. Our business includes Ostomy Care, Continence Care, Wound and Skin Care and Interventional Urology. We operate globally and employ about 12,500 employees.

The Coloplast logo is a registered trademark of Coloplast A/S. © 2022-01.
All rights reserved Coloplast A/S, 3050 Humlebaek, Denmark.

Dennis Kaysen Sr. Director, Communications Tel. +45 4911 2608 Email: dkdk@coloplast.com